Prosecution Insights
Last updated: November 18, 2026
Application No. 18/633,424

INTERLOCK ASSEMBLY FOR A MICROCATHETER DEVICE

Final Rejection §102
Filed
Apr 11, 2024
Priority
Apr 13, 2023 — provisional 63/459,119
Examiner
SCHMIDT, EMILY LOUISE
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Scientia Vascular Inc.
OA Round
2 (Final)
58%
Grant Probability
Moderate
3-4
OA Rounds
95%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
596 granted / 1020 resolved
-11.6% vs TC avg
Strong +36% interview lift
Without
With
+36.5%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
56 currently pending
Career history
1103
Total Applications
across all art units

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Cottone (US 11,007,345 B2). With regard to claims 1-5, Cottone teaches an interlock assembly for a catheter, comprising: a microfabricated tube (Fig. 1A member 100) comprising a distal ring, the distal ring comprising at least one ring tenon and at least one ring mortise (exemplary Fig. 4(b), ring portion is the distal portion of 110 in the area of 150 distal of the cuts, the tenons are on either side of 150, 460, and 461, mortises formed by 150, 460, and 461), wherein the microfabricated tube comprises a fenestrated segment extending from a main segment of the microfabricated tube to the distal ring of the microfabricated tube (Figs. 2A and 3 segment 110, spiral fenestrations 340); and a marker band (Fig. 1(a) considered as portions 120 and 170) comprising at least one band tenon and at least one band mortise (exemplary Fig. 4(b) tenons 140, 450, and 451, mortises formed by spaces between 140, 450, and 451), wherein the at least one ring mortise is configured to receive and interlock with the at least one band tenon and wherein the at least one band mortise is configured to receive and interlock with the at least one ring tenon (exemplary Fig. 4(a)). With regard to claims 6 and 7, alternatively the snap fit connector 510 in Figs. 5 is considered which has an opening between 550 and 560, further see coating 1010 and 1020 (Fig. 10(b)). The snap fit shape can vary and is considered as the at least one tenon, this portion may be on either member (Col. 10 lines 17-32). With regard to claim 8, see Col. 3 lines 50-59 regarding the radiopaque material, the tube can include nonradiopaque materials which include polymers or other metals (see at least Col. 2 line62-Col. 3 line 30). With regard to claim 9, see exemplary Fig. 6(r), the tenons are curved. With regard to claims 10 and 11, the tenon on either side of 150 has a greater width than the tenons which fit into 460 and 461 (Fig. 4(b)). Cottone teaches the snap portions may be configured on either member (Col. 10 lines 17-20) and when reversed the length of the ring tenon is less than the band tenon. With regard to claim 12, see Fig. 19(d), member 1900b. With regard to claim 13, Cottone teaches the snap portions may be configured on either member (Col. 10 lines 17-20), see exemplary Fig. 6(l) 150 expands and contracts. Alternatively, portions 530 and 540 move inward to connect (Col. 16 line 58). With regard to claim 14, Cottone teaches an interlock assembly for a catheter, comprising: a microfabricated tube (Fig. 1A member 100) comprising a distal ring, the distal ring comprising at least two ring tenons and at least two ring mortises (exemplary Figs. 5, ring portion is the distal portion of 110 in the area of 120 distal of the cuts, the tenons are on either side of 120, and to the sides of spaces generally indicated as 460, and 461 in Fig. 4(b), mortises formed by 120 and corresponding spaces), wherein the microfabricated tube comprises a fenestrated segment extending from a main segment of the microfabricated tube to the distal ring of the microfabricated tube, wherein the fenestrated segment is a helical segment, and wherein the distal ring is integrally connected to the helical segment to form a monolithic structure (Figs. 2A and 3 segment 110, spiral fenestrations 340); and a marker band (Fig. 1(a) considered as portions 120 and 170) comprising at least two band tenons and at least two band mortises, wherein each ring mortise is configured to receive and interlock with a corresponding band tenon and wherein each band mortise is configured to receive and interlock with a corresponding ring tenon, wherein at least one ring tenon of the at least two ring tenons, or at least one band tenon of the at least two band tenons, comprises a radial aperture, and wherein an outer laminate extends through the radial aperture (Figs. 5 one tenon formed by 530 and 540 with aperture in-between, additional tenons formed by members which fit into spaces of the other segment, further see coating 1010 and 1020 (Fig. 10(b)).). With regard to claim 15, Cottone teaches multiple snap connections may be used, as such at least two are used and that the connector and acceptor can be on either or both members (Col. 15 line 64-Col. 16 line 8). As such this can result in a situation where two sets of members 530 and 540 with an aperture between are provided on each portion. With regard to claim 16, see Col. 3 lines 50-59. With regard to claim 17, see exemplary Fig. 6(r), the tenons are curved. With regard to claims 18 and 9, portions on either side of 120 are wider than corresponding tenons on the other side. Cottone teaches the snap portions may be configured on either member (Col. 10 lines 17-20) and when reversed the length of the ring tenon is less than the band tenon. With regard to claim 20, portions 530 and 540 move inward from an expanded configuration to connect (Col. 16 line 58). Response to Arguments Applicant's arguments filed September 23, 2026 have been fully considered but they are not persuasive. Regarding claims 1 and 14, Applicant argues 120 and 170 are not marker bands because there are radiopaque materials that encircle these portions. As these band portions include radiopaque material they are taken as a whole to be marker bands. Further, claim 1 does not specify a radiopaque material or to what extent that material is provided in the band. Even if the radiopaque material were not considered the bands may be considered as markers as they mark a location along the catheter. Regrading claims 14, 6, and 7, Applicant argues there is no radial aperture. Members 530 and 540 are considered together to form the tenon, in between these portions there is a space with a curved vertex which provides a radial aperture. Further, as the outer laminate coating covers the joints it would bond through that space. Regarding claim 8, Applicant argues radiopaque material is not disclosed as forming the interlocking joint between tubes, this is not claimed. The amendments are sufficient to overcome the previous objections. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to EMILY L SCHMIDT whose telephone number is (571)270-3648. The examiner can normally be reached Monday through Thursday 7:00 AM to 4:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at 571-272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /EMILY L SCHMIDT/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Apr 11, 2024
Application Filed
Jul 02, 2026
Non-Final Rejection mailed — §102
Sep 23, 2026
Response Filed
Oct 21, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788891
AUTO-INJECTOR WITH ANTI-ROLL FEATURES
4y 1m to grant Granted Nov 10, 2026
Patent 12766264
NEEDLE-FREE INTRADERMAL INJECTION DEVICE
4y 12m to grant Granted Oct 20, 2026
Patent 12758747
NEUROSURGICAL APPARATUS AND METHODS
2y 8m to grant Granted Oct 13, 2026
Patent 12752059
INJECTION DEVICE AND A REUSABLE PART THEREFOR
4y 1m to grant Granted Oct 06, 2026
Patent 12741098
DEVICES AND METHODS FOR PRECISION DOSE DELIVERY
4y 2m to grant Granted Sep 22, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
58%
Grant Probability
95%
With Interview (+36.5%)
Moderate
PTA Risk
Based on 1020 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month